Following the strong recovery in 2024, F88 continues to fare well in the first quarter of 2025 with significant improvements ...

U Power Limited (Nasdaq: UCAR), a global leader in a global leader in green smart energy grid innovation, announced that its ...

Global AT2R-targeted drug development remains nascent, with only a few competitors like Lilly-partnered CFTX-1554 (Phase I).

TERREPOWER, a global leader in sustainable manufacturing, specializing in providing high-quality, reliable products to the ...

A potential game changer in the treatment of retinal disease, the novel dual-target drug shows encouraging results.

SINGAPORE, May 6, 2025 /PRNewswire/ – Smart Digital Group Limited (the "Company") (Nasdaq: SDM), a digital marketing service ...

Clinical pipeline: 67 distinct antiviral compounds are currently in active clinical development, with 22 approved compounds ...

Lexington Partners is one of the world's largest and most experienced managers of secondary and co-investment strategies, ...

Stocks: Stocks experienced an extraordinary growth rate of 645.60% compared to Q1 2024, and a 97.59% increase compared to Q4 ...

As FinPrime celebrates this latest achievement, the firm remains committed to driving innovation and delivering exceptional ...